Mono Pharmacre Ltd — Quarterly Results & Earnings

₹11.15

-4.70%

Profit Growth YoY-99.13%Latest quarter

Sales Growth YoY-23.94%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-99.13%

🔴 Significant decline

YoY Sales Growth-23.94%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

1.35

ROE

10.42%

ROCE

11.00%

💡

Growth Analysis

Mono Pharmacre Ltd reported YoY profit growth of -99.13% and revenue growth of -23.94% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Mono Pharmacre Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.